






De Luca, S. N., Miller, A. A., Sominsky, L. and Spencer, S. J. (2020) Microglial 
regulation of satiety and cognition. Journal of Neuroendocrinology, 32(3), e12838. 
(doi: 10.1111/jne.12838). 
 
   
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
This is the peer reviewed version of the following article:  
De Luca, S. N., Miller, A. A., Sominsky, L. and Spencer, S. J. (2020) Microglial 
regulation of satiety and cognition. Journal of Neuroendocrinology, 32(3), e12838, 
which has been published in final form at 10.1111/jne.12838. This article may be 




































Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
	 1	
Microglial regulation of satiety and cognition 
 
Simone N. De Luca1, Alyson A. Miller3, Luba Sominsky1, Sarah J. Spencer1, 2* 
 
1School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic., Australia. 
2ARC Centre of Excellence for Nanoscale Biophotonics, RMIT University, Melbourne, Vic., 
Australia. 3Institute of Cardiovascular & Medical Sciences, British Heart Foundation 




School of Health and Biomedical Sciences RMIT University, Melbourne, Vic., Australia. 
3083. Phone: +61 3 9925 7745 
 
Acknowledgements: This project was supported by funding from a National Health and 
Medical Research Council Career Development Fellowship II (APP1128646) to SJS, an 
RMIT University Vice-Chancellor’s Senior Fellowship to AAM, an RMIT University Ph.D 
Scholarship and Publication Grant to SND, and an RMIT Vice-Chancellor’s Postdoctoral 
Fellowship to LS. We had significant figure illustration assistance from Alison Schroeer. 
 









Microglia have been known for decades as key immune cells that shape the central nervous 
system (CNS) during development and respond to brain pathogens and injury in adult life. 
Recent findings now suggest that these cells also play a highly complex role in several other 
CNS functions. In this review, we will provide a brief overview of established microglial 
functions in development and disease. We will also discuss emerging research suggesting 
microglia are important in both cognitive function and the regulation of food intake. With 
respect to cognitive function, current data suggest microglia are not indispensable for 
neurogenesis, synaptogenesis or cognition in the healthy young adult, but crucially modulate 
and support these functions. In doing so they are likely important in supporting the balance 
between apoptosis and survival of newborn neurons and in orchestrating appropriate synaptic 
remodelling in response to a learning stimulus. We also explore the possibility of a role for 
microglia in feeding and satiety. Microglia have been implicated in both appetite suppression 
with sickness and obesity and in promoting feeding under some conditions and we discuss 
these findings here, highlighting the contribution of these cells to healthy brain function.     
 





Microglia are resident innate immune cells of the central nervous system (CNS). They are in 
direct contact with and interact with neurons and synapses, as well as other glial cells in the 
CNS parenchyma 1-3. During brain development, they are important in regulating neuronal 
survival and death, synaptogenesis and angiogenesis and in adults they are key in responding 
to brain injury and pathogens 4. Recently, additional roles for these cells in the healthy brain 
are starting to emerge along with evidence that subtypes with distinct functions are important 
in central responses to challenge 5-8. In this review, we will present a brief overview of 
microglia’s known roles in development and in responding to pathogens and injury, but will 
also discuss new evidence suggesting microglia play an integral role in at least two fairly 
disparate physiological functions in the healthy adult animal: cognition and satiety signalling. 
We will confine our discussion here to microglia and direct the reader to excellent recent 
reviews covering the roles of astrocytes and other CNS cell types 9, 10. Understanding of these 
novel roles for microglia is being made possible because of the development of several new 
pharmacological and transgenic strategies for manipulating these cells. Traditional 
pharmacological strategies including liposomal clodronate 11 and minocycline 12, 13 have 
recently been added to with colony stimulating factor receptor 1 (CSF-R1) kinase inhibitors 
PLX3397 14, 15 and PLX5562 16, 17 (so far exclusively used in mice). In the transgenic space, 
there are now total knockouts for several microglia-specific genes that results in death of 
these cells (e.g. chemokine, CX3C motif, receptor 1 (-/-) [cx3cr1(-/-)], complement receptor 
3 [CR3(-/-)], and DAP12(-/-)18). The diphtheria toxin receptor (DTR) model 
CX3CR1CreER:iDTR in mice exploits the idea that at least a population of microglia are 
longer-lived than circulating monocytes 19. Cx3cr1-Dtr rats offer a strategy for rat microglia-
specific ablation 20. Each of these strategies carries limitations; ones of specificity with the 
traditional pharmacological agents, developmental in the total knockouts. The PLX 
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compounds require a protracted time frame for microglial depletion 21, precluding their use in 
neonatal or acute applications. There is also a suggestion that only a subset of microglial 
genes may be affected 22. The CX3CR1CreER:iDTR mouse may be limited by at least some of 
the microglia rapidly replacing themselves 23. In the Cx3cr1-Dtr rat, monocytes are also 




2.1. A brief history of microglia  
Microglia were first identified in 1899 by Franz Nissl and W. Ford Robertson in their 
description of “reactive glial elements” 24. The term microglia was coined by Pio del Rio-
Hortega in the early 20th century, who described their activation in response to brain injury; 
their non-neuronal elements that were distinct from the neuroectodermal macroglia, 
oligodendroglia and astroglia; and their origin from the mesoderm 24-26.  
 
Despite some early controversy 27-29, it is now established that microglia likely have a yolk 
sac origin, deriving from undifferentiated hematopoietic precursors and moving into the brain 
in two waves, initially via interstitial migration prior to the development of the cerebral blood 
vessels and the blood-brain barrier, as well as before the production of monocytes in 
hematopoietic tissue 30, 31, and later through the blood circulation 30. By approximately P42 in 
rodents 23, 32, microglial numbers have refined to those maintained throughout adulthood and 
at this stage microglia make up approximately 5-15% of cells within the brain 33. Historically 
thought to be remarkably long-lived based on H3 thymidine labelling 34, recent data now 
suggest that at least a proportion of microglia turn over much more rapidly, with a possible 
replacement rate of 96 days for the whole population in the rodent given a uniform turnover 
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23. In this study, turnover rate was estimated using 5-bromo-2'-deoxyuridine (BrdU) 
incorporation - a thymidine analogue that is incorporated into the S phase of the cell cycle 
during DNA replication 23. In an unrelated study using samples from two human patients, 
microglia were found to have an average age of 4.2 years and to renew at a rate of 28% of the 
microglia in the cortex being replaced per year; calculated using comparison of the 14C levels 
in the microglial DNA relative to the atmospheric 14C curve, with cells as old as the 
individual having 14C levels corresponding to the level at birth and newer cells having 14C 
levels corresponding to the number of divisions made 35.  
 
Through development, microglia express an age-dependent gene signature and morphology, 
shifting from an ameboid morphology (large round soma, few to no processes) in early life to 
a ramified morphology (smaller soma, many complex processes) as the animal matures 36, 37. 
In the adult animal, microglial morphology differs throughout the brain depending upon the 
tissue type, region, age, sex and presence or absence of an immune challenge or injury 5, 24. 
Very broadly, however, microglia display a highly ramified “surveillant” morphology under 
unstimulated conditions, at which time they are highly motile, with continuous extension and 
retraction of their thin long processes, while the soma remains relatively stationary. In the 
presence of a significant injury, however, microglial cells rapidly extend their processes 
toward the stimulus and take on a more ameboid morphology, as seen with two-photon 
microscopy 38, 39.  
 
2.2. Microglia’s role in brain development  
During embryonic and postnatal brain development, microglia play essential roles in several 
processes of brain network refinement 4. They are aligned along the axonal tracts, supporting 
their development 18. They refine neuronal networks by promoting programmed cell death 
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and phagocytosis of apoptotic cells 40. They also regulate synapse formation and pruning, 
through the removal of synaptic spines 41, 42. Their key importance in these processes is 
supported by many studies, not least a recent case of a human baby born without functional 
microglia due to a CSF-1R mutation. In this case, brain networks were severely disrupted, 
with increased neuron number and aberrant neuronal connectivity 43. 
 
Neuronal apoptosis and survival 
During embryonic development, high densities of microglial cells are seen alongside specific 
developing axonal tracts, particularly on dopaminergic axons 18. Elimination of microglia, 
using cell-depletion approaches and cx3cr1(-/-), CR3(-/-), and DAP12(-/-) mutants, causes an 
increased dorsal outgrowth of these axons, while maternal immune activation (and thus 
microglial activation) restricts dorsal extension and is associated with a pronounced ventral 
increase in dopaminergic innervation 18. 
 
During the late stages of cortical neurogenesis, microglia are ameboid in morphology, 
phagocytic in activity, and actively phagocytose neural precursor cells (NPC) 11. If microglial 
activation is suppressed at this time, or if microglia are depleted, there is a significant 
increase in the number of NPCs as a consequence of a reduction in phagocytosis 11. 
Conversely, during early postnatal development microglia promote the survival of cortical 
neurons in the subcortical white matter in an insulin-like growth factor-1-dependent manner, 
as determined using minocycline as well as CD11b-DTR and Cx3cr1-deficient mice 44. 
 
Synaptic pruning and formation 
During early brain development, microglia also play a key role in eliminating supernumerary 
synapses and refining synaptic networks 3. For example, during rodent development, the 
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retinal ganglion cell inputs from both eyes overlap until the beginning of the second postnatal 
week and are thereafter rearranged to eye-specific regions. This process involves selective 
pruning of these projections and is known to be mediated by the activation of the complement 
pathway with microglial cells pruning those synapses that localize complement cascade 
initializing protein q (C1q) and complement 3 (C3) 42, 45. Deficiencies in this pathway can be 
encouraged either by eliminating the CR3 receptor (with CR3 knockout mice) found on 
microglia or by reducing the neuronal ligands C1q or C3 (with knockout mice), leading to 
reduced synaptic pruning. Such impairment of synaptic elimination induces retinogeniculate 
projection segregation deficits that can be observed long-term in the adult brain 46.  
 
Pruning of supernumerary synaptic elements has also been shown in the hippocampus during 
the first postnatal weeks of development in rodents via electron and stimulated emission 
depletion microscopy of excitatory post-synaptic density (PSD-95) and pre-synaptic 
terminals (SNAP25) in the cytoplasm of microglial cells, suggesting that microglial cells 
phagocytose the synaptic elements 41. Paolicelli et al. have also demonstrated that pruning of 
supernumerary dendritic spines is delayed in the hippocampus of Cx3cr1 knockout mice, in 
which there is a delay of microglial cell recruitment 41. These mice also show maturation 
deficits in the functional properties of their excitatory synapses 41, 47. Microglia have also 
been identified to play a role in synaptic pruning in the cerebral cortex in non-human 
primates as is indicated by the similarities in the time course of synaptic and microglial gene 
pathway changes  48, 49. Recent evidence suggests that a direct phagocytic role in 
development may not be the major mechanism by which microglia regulate synaptic 
maturation, rather that they may act via a process of trogocytosis, or “nibbling” of synaptic 
elements to reshape the synaptic material 50.  
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Alongside, microglia’s role in synapse elimination, it is now clear that these cells also 
influence early life synaptic formation and functional synapse maturation, likely through the 
release of growth factors and cytokines 51, 52. In particular, microglial elimination in juvenile 
mice impairs the turnover of spines in the pyramidal neurons of the motor cortex resulting in 
fewer dendritic spines in this region 19. This reduction of dendritic spine formation was 
reproduced with specific knockout of brain-derived neurotrophic factor (BDNF) in microglia, 
suggesting that microglial production of this growth factor is essential for the formation of 
new spines in the neonatal cortex and this influences performance during motor learning and 
fear conditioning in adulthood 19. Particular cytokines are also known to impact synaptic 
functions and could therefore be considered as important microglia-dependent mediators of 
postnatal synaptic maturation. For instance, interleukin (IL)-1β is a proinflammatory 
cytokine produced by microglia as well as other CNS cells. Deficits in hippocampal synaptic 
plasticity and in cognitive functions programmed by microglial maturational delay in Cx3cr1 
knockout mice are rescued by antagonising IL-1β signalling 53.  
 
2.3. Microglia’s role in responding to pathogens and injury 
Early on in the scientific history of microglia, it was established that these cells are highly 
responsive to pathogens and injury in both the developmental phase and in adulthood 24-26. In 
response to acute injury, microglia phagocytose cellular debris, which can be seen in bulbous 
formations at their ends with in vivo two-photon live imaging 38, 39. This function is mediated 
typically by two types of receptors that respond to the “eat me” “don’t eat me” signals 
(phagocytic machinery and signalling pathways) upon recognizing pathogen- and danger-
associated molecular patterns on pathogens, from metabolic products or dying/dead cells 24, 
54. Microglial functional diversity is demonstrated in their differential responses to specific 
stimuli. When stimulated by microbial components, such as lipopolysaccharide (LPS), 
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microglial cells react by activating a phagocytosis program that involves activation of toll-
like receptors (TLRs) leading to transcription of pro-inflammatory mediators including 
cytokines 55. These cytokines have been found to be neurotoxic at high concentrations and to 
also increase inflammation (e.g. tumor necrosis factor -α; TNF-α), and induce fever and 
other aspects of sickness behaviour (e.g. IL-6) 56, 57. Cytokines also regulate presentation of 
cell surface molecules involved in microglial activation and microglial-neuronal interactions 
(e.g. interferon γ; IFNγ) 24. Importantly, humans, unlike rodents, have relatively low 
microglial TLR4 expression and no detectable IFNγ receptor expression. These differences 
need to be taken into consideration when translating rodent data to humans 58, 59. Alternative 
to this pro-inflammatory response, when microglial cells are challenged by apoptotic cells or 
myelin debris, they respond by releasing anti-inflammatory agents that downregulate the 
effects of pro-inflammatory cytokines and promote neuronal survival 60. Cytokines such as 
IL-10, IL-4 and transforming growth factor (TGF)-β are anti-inflammatory and modify cell 
surface receptor expression on microglia and also downregulate the expression or attenuate 
the effects of pro-inflammatory IL-1β and TNF-α 61. 
 
Clearly microglia are important for perinatal brain development and disruptions to their early 
activity can have a lasting impact on cognitive function, at least. Microglia’s role in the 
presence of pathogens and injury is also relatively well understood 38, 39. However, the 
function of these cells while in “surveillance” mode in the adult brain is only just being 
recognised. Evidence now suggests these dynamic cells may have an ongoing role in synaptic 
remodelling, cognition, and other functions, as the animal progresses through adulthood.  
 
3. Microglia’s role in cognition 
3.1. Microglia in cognition 
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Microglia are well-known to be involved in the cognitive dysfunction associated with a 
variety of diseases, as well as with ageing. Several excellent reviews detail our current 
knowledge on this topic with respect to pathological conditions 62-64 and so we will focus here 
principally on how these cells may be integral in cognition in the healthy young adult. Recent 
advances in microglial transgenic models and other methods for manipulating microglial cells 
have enabled us to identify that these cells may not be indispensable for adult neurogenesis, 
synaptogenesis, and cognition to occur but, rather, may modulate and support these functions. 
However, the direction of their contribution remains surprisingly unclear. 
 
There is some evidence to suggest microglial activation is detrimental to cognition and that 
removing microglia altogether may be beneficial. Cope and colleagues have recently shown 
that 10 weeks of high-fat diet in the mouse leads to microglial activation in the hippocampus, 
as well as cognitive deficits, and preventing this activation with knockdown of the fractalkine 
receptor or with minocycline restores cognition 65. Although microglial activation outside of 
the hypothalamus is rarely seen with short-term high-fat feeding, there is evidence to suggest 
that it can occur with longer exposures and that this may be linked with cognitive dysfunction 
66-68. In this case, microglia may be encouraged in excessive pruning of dendritic spines by an 
over-activation of the complement signalling pathway initiated at the level of the neuron, 
since annexin-V, a compound that blocks microglial phagocytosis by binding to “eat me” 
phosphotidylserine residues on dying cells, also completely restores cognition 65. In ageing 
rats, microgliosis and microglial priming are also associated with cognitive decline and 
microglial priming in the amygdala, in particular, is linked to poor cognitive outcomes 69-72. 
On the other hand, activation of microglia in young animals in a spatial learning task is 
associated with successful performance of that task 73 and is in accordance with a possible 
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role for microglia in supporting survival of neurons at the appropriate stage of maturity to 
respond to the task.  
 
If microglial activation is universally detrimental to cognitive function, one might expect that 
cognition would be improved in the absence of these cells and impaired as they repopulate. 
Although there is evidence that this might occur under some conditions, these findings are 
not ubiquitous. Elmore and colleagues have shown that long-term near-complete microglial 
ablation in mice with a CSF-1R inhibitor does not negatively impact learning and memory, 
and may benefit spatial memory in the Barnes maze 15. In our own studies we have seen that 
acute microglial ablation in our Cx3cr1-Dtr transgenic rat that allows diphtheria toxin (DT) 
to specifically ablate microglia and monocytes (which express the fractalkine receptor, 
Cx3cr1), does not impair novel object recognition or place recognition memory (De Luca, 
Sominsky, Spencer et al, 2019, unpublished observations). Likewise, acute pharmacological 
suppression of microglial activity does not affect cognition in non-obese mice 65. Notably, 
Elmore and colleagues have shown in aged rats 74, and we have demonstrated in the young 
(De Luca, Sominsky, Spencer et al, 2019, unpublished observations), that repopulating 
microglia (after treatment with CSF-R1 inhibitor, PLX5622 in the former study and after 
ablation with DT in Cx3cr1-Dtr transgenic rats in the latter) transiently support an 
improvement in cognitive function. On the other hand, other work has shown detrimental 
effects of early microglial repopulation on motor learning in a rotarod task 19 and in social 
behaviour in a Crawley’s sociability task 14.  
 
The differences between these findings may be due to duration of depopulation and degree of 
repopulation. For instance, Torres and colleagues showed that a short period of microglial 
ablation, with CSF-R1 inhibitor PLX3397 for 7 days, leads to transient spatial memory 
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impairments in the Barnes maze with longer escape latencies during training. However, these 
impairments dissipate with a longer depletion period of 21 days 14, while a longer ablation 
protocol (2 months of PLX3397) enhances spatial memory in the Barnes maze, with shorter 
escape latencies and reductions in the average escape latencies across all training days 15. 
Timing with respect to repopulation may also be important. For instance, our data with the 
Cx3cr1-Dtr rat suggest there is a transient improvement in memory after microglial ablation 
that coincides with a time at which the microglia have repopulated in number but display an 
ameboid “activated” morphology (De Luca, Sominsky, Spencer et al, 2019, unpublished 
observations). Interestingly, Rivest and others provide data to suggest that neuroprotective 
bone marrow-derived microglia are recruited to the brain under certain pathological 
conditions and these infiltrating microglia behave differently from the resident ones. 
Potentially microglial repopulation in models of ablation involve these peripherally-derived 
recruited microglia 75, 76. However, the question remains, how might microglia both support 
and suppress cognitive function? 
 
3.2. Mechanisms for microglial modification of cognitive function 
Under normal physiological conditions, neurogenesis has been found in the subgranular zone 
(SGZ) of the dentate gyrus 77, 78 and the subventricular zone of the lateral ventricles 79 and is a 
key substrate for cognitive flexibility and long-term memory. Hippocampal neurogenesis is 
maintained by the proliferation of neural stem cells located in the SGZ 80, 81. Only a few 
newborn cells are incorporated into the circuitry - the majority are presumed to die at the 
immature neuron stage in the first one to four days of their life 82. Sierra and colleagues have 
shown that unchallenged ramified microglia are an essential component of the neurogenic 
SGZ niche and that microglia physically intermingle with NPCs, neuroblasts and newborn 
neurons, phagocytosing newborn neurons that are apoptotic 83. Which neurons survive seems 
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to depend upon the timing of their birth with respect to their recruitment by learning tasks. 
Thus, when a stimulus is received, new neurons that are not sufficiently mature to propagate 
action potentials upon stimulation may be recruited to an apoptotic pathway, while young 
neurons that are sufficiently mature to respond are further strengthened and are more likely to 
survive long-term 84-86. In support of this, undergoing a learning task, such as the radial arm 
maze, leads to fewer immature neurons (doublecortin (DCX)-positive) surviving in the 
hippocampus at the conclusion of the task 73. Likewise, those with the highest learning-
induced reduction in newly proliferating cells, as labelled with BrdU, perform the best in the 
Morris water maze (MWM) 84. Preventing apoptosis in the late, consolidation, phase of the 
MWM task, by inhibiting caspase-3, delays acquisition of the spatial memory 85. It is 
noteworthy that microglia are highly activated in spatial learning tasks, potentially 
encouraging or cleaning up after this additional apoptosis 73. 
 
Complicating the story somewhat is evidence to suggest that increased adult neurogenesis in 
the hippocampus is associated with rewarding experiences such as environmental enrichment, 
mating or physical activity, all of which have been shown to be positive for cognitive 
function 87. Alternatively, aversive experiences commonly associated with microglial 
activation and inflammation such as stress, immune challenges, aging and social defeat 
exposure lead to a short-term decrease in the production of new neurons 88. Interestingly, 
central inflammation can be associated with a “rebound” increase in neurogenesis above pre-
challenge levels once the inflammation has resolved 89. Together these data suggest adequate 
neurogenesis is necessary for appropriate cognition, but activity-dependent selection of which 
of these cells survive is also essential and microglia may be important in regulating this.  
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Synaptogenesis and synaptic remodelling are also an important mechanism for successful 
cognition with deficits in synaptic plasticity leading to cognitive disorders 90. Microglia’s role 
in synaptic plasticity is illustrated by recent research showing synaptic proteins are 
selectively eliminated by microglia during sleep 91 and cathepsin S, a microglial-specific 
lysosomal cysteine, is secreted by microglia during the dark (active) phase to decrease the 
spine density of cortical neurons leading to a reduction in synaptic strength during the 
following light (inactive) phase 92. Notably, then, the detrimental effects of microglial 
ablation on motor learning are linked to a reduction in synapse formation in the motor cortex 
in the learning phases of this task 19. Likewise, the detrimental effects of high-fat diet on 
novel object recognition performance can be restored by preventing excessive microglia-
mediated pruning of dendritic spines 65. These data again suggest that both the absence of 
microglia and their excessive activity can encourage excess synaptic pruning with a negative 
outcome for cognition. In this regard, it is clear that a balance of appropriately dynamic 
dendritic spines is important for learning and memory. For example, females show 
fluctuations in dendritic spine density by up to 30% across the ovarian cycle but can display 
equal success in memory tasks while employing different recall strategies 93, 94. These data 
suggest that a balance of appropriately active microglia is important for optimal learning and 
memory and that neither too much nor too little input from these cells is of benefit, that the 
balance between mature and immature neurons and dendritic spines are key encoders for 
successful memories and that microglial cells are important in achieving this (Fig. 1). 
 
4. Microglia’s role in satiety 
There is a strong body of data to support a role for microglia in cognitive function under 
pathological conditions and so this recent work revealing a more subtle contribution of these 
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cells in cognition in healthy adults comes as no real surprise. However, the role of microglia 
in feeding and satiety is a much more recent addition to our knowledge of their repertoire.  
 
4.1. Microglia in satiety in sickness and obesity 
Microglia do have an established role in the anorexia associated with sickness behaviour, the 
collective fever, withdrawal, and appetite suppression that is seen in response to 
neuroimmune challenge 95. Microglia are likely to be involved in all aspects of this response, 
and microglial activation with visfatin or TLR2 activation leads to increases in pro-
opiomelanocortin (POMC) neuronal activity and a suppression of food intake co-incident 
with other aspects of the sickness response 96, 97. 
 
Microglia may also be involved in the dysregulated appetite associated with obesity. 
Microglial activation is a key factor in obesity and can be seen in the brain prior to evidence 
of peripheral inflammation 98. Indeed, high-fat diet feeding leads to early microgliosis that is 
protective against the detrimental effects of the diet on the health of POMC neurons 99, 100. 
Prolonged high-fat diet, on the other hand, is linked with a second wave of microgliosis that 
occurs in conjunction with POMC cell death 100. Notably, the degree of microglial activation 
is well-correlated with the degree of weight gain in mice fed high-fat diet 100, 101 and 
inhibiting microglial proliferation with Ara-C reduces high-fat diet-induced weight gain 102. 
However, it is still unclear if microglial activation is a cause or an attempt-at-a-protective 
consequence of obesity. Preventing microglial activation with minocycline fails to restore 
body weight in high-fat diet-fed mice of the same strain as that used for the Ara-C 
experiments 65. Likewise, microglial priming associated with ageing does not automatically 
lead to obesity in this population and circadian rhythm disruption with dim light at night 
leads to weight gain in the absence of changes in microglial morphology 103. Notable sex 
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differences in susceptibility to high-fat diet illustrate that microglial activation may be a 
compensatory response to the loss of a CX3CL1-CX3CR1 interaction in males since female 
mice, in contrast, retain normal CX3CL1-CX3CR1 signalling capacity with high-fat diet and 
are also protected, relative to males, from diet-induced obesity and microgliosis 104. 
 
4.2. Microglia in satiety 
Microglia’s role in satiety in healthy adults (if any) is also still unclear. Early conflicting 
evidence has suggested microglia can a) not affect b) suppress and c) promote appetite and 
feeding. We will discuss this contrasting evidence here.  
 
Evidence that microglia do not affect feeding  
Several recent studies have employed the PLX compounds PLX3397, 5622 and 647 to 
suppress expression of CSFR1 in mice. Whether these compounds ablate microglia 15 or 
suppress a subset of microglial-related genes 22, these cells can no longer be seen in the brain 
after 3 weeks’ treatment with this compound and microglia-typical functions, such as the 
response to LPS, are impaired 15. Microglial-related pathologies can also be improved with 
these compounds 74, 105. However, appetite and feeding remain largely unaffected, at least in 
adults. As such, the few studies that report food intake or body weight after exposure to PLX 
compounds report them to be unchanged in chow-fed young adult mice 21, 106, 107. Similarly, 
studies employing other pharmacological agents to block microglial proliferation, activity, or 
interactions with neurons (e.g. AraC, mice, 15 µg/µL icv at 0.11 µL/L for 4 weeks 102; 
minocycline: mice, 40 mg/kg in drinking water for 2 weeks 65; annexin-V: mice, 200 µg/kg iv 
for 3 days 65) also often show no effect on weight in control animals 65, 102. It is noteworthy, 
though, that all these compounds take several days to influence microglia and there are few 
reports of body weight data early after commencement of drug administration when 
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microglial activity is beginning to be impaired. In this respect, it is worth observing that 
Djogo and colleagues found no significant differences between controls and PLX3397-
treated mice at 7 days after commencement of treatment, but there was a notable trend 
towards a reduced body weight at day seven (97 versus 101% of starting weight) and no 
reported weight measurements earlier than this 21. Particularly with agents such as the PLX 
compounds that are administered in the diet, careful early weight measurements and reports 
of diet consumption will be necessary to clarify if the microglial inhibition alters satiety, the 
diet is merely unpalatable, or it has no effect at all.  
 
Evidence that microglial activity suppresses feeding 
Findings from the above studies notwithstanding, there is also robust evidence that microglia 
can suppress feeding. Evidence from slice preparations suggests acute microglial activation 
leads to an inhibition of orexigenic agouti-related peptide (AgRP) neurons and an excitation 
of anorexigenic POMC neuron firing in the hypothalamic arcuate nucleus (ARC), consistent 
with microglia’s role in sickness behaviour and with microglial activity suppressing food 
intake 108. Likewise, inhibiting microglia with icv minocycline acutely increases food intake 
108 and caloric restriction suppresses microglial activation 109. These findings suggest 
microglia are at least capable of suppressing feeding when activated and may maintain 
normal feeding drive under unstimulated conditions.  
 
There is also some work to suggest that microglia may be involved in developmental 
programming of feeding circuitry to register satiety. Specific depletion of microglial leptin 
receptors with an ObRloxP-Cx3cr1-Cre mouse closely replicates the db/db phenotype of 
leptin resistance. These mice have hyperphagia and increased body weight. They also have 
reduced POMC neuron numbers in the ARC and a reduced density of α-melanocyte-
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stimulating hormone (α-MSH) projections from the ARC to the paraventricular nucleus of 
the hypothalamus (PVN) 110. Likewise, mice with microglial ablation with the CSF-R1 
inhibitor, PLX5622, throughout the embryonic period have reduced POMC neuron numbers 
postnatally along with accelerated weight gain 111. Although, it must be considered that this 
manipulation was associated with a number of other abnormalities.  
 
Evidence that microglial activity promotes feeding 
As discussed above for models of obesity, there is also some evidence that microglial 
activation can promote feeding. In humans, suppression of microglial activity with 
minocycline can lead to weight loss 112, a finding that is opposite to this compound’s effects 
when given icv in the mouse, potentially reflecting its action on the gut when given orally 113. 
However, in a mouse model, specific inactivation of microglia with PLX5622 reduces food 
intake in high-fat diet fed mice (but, as discussed, not in chow-fed 106). In addition, we have 
recently demonstrated that microglial depopulation in the Cx3cr1-Dtr transgenic rat leads to 
an acute suppression of food intake and a corresponding weight loss that is restored as the 
microglia repopulate 20. This anorexia in the absence of microglia occurs without any 
evidence of central or peripheral inflammation as assessed by circulating and brain cytokine 
levels and gene expression; and without other sickness behaviours such as reduced 
exploratory activity or pica to suggest it is related to an inflammatory response 20.  
 
Our findings in this study 20 suggest that the changes in feeding behaviour are not due to 
changes in peripheral hormonal signals such as ghrelin and leptin. They are also unlikely to 
be due to a direct effect on neuronal networks at the level of the ARC, since microglial 
ablation leads to increased density of neuropeptide Y (NPY) and reduced numbers of neurons 
expressing POMC, both of which would normally lead to increased food intake. We 
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speculate that the absence of microglia may lead to a suppression of feeding by enhancing the 
anorexigenic output of the paraventricular thalamus (PVT) to the basolateral amygdala, a 
circuit that interacts with the PVT’s orexigenic networks to establish valence in satiety-
sensing 114, 115. In support of this idea, we see greater neuronal activation in the PVT in 
response to feeding in the absence of microglia. Further work will need to directly test the 
contribution of microglia to the activation of this feeding circuit. 
 
Integrating microglia’s role in feeding 
Together, these data suggest microglia can influence feeding under certain adverse 
conditions, such as with obesity and neuroimmune challenge. In these latter cases, microglial 
activation is associated with anorexia, but it is still not clear if such activation is effecting the 
anorexia or is a compensatory response to resolve it. There also seems to be a role for these 
cells in acutely influencing feeding in healthy adults in the absence of neuroimmune or other 
stimulation. As such, microglia in surveillance mode may help to integrate satiety 
information at the level of the PVT and other regions to stimulate or suppress feeding 20. 
Further evidence of microglia’s important role in modulating feeding and satiety (potentially 
in both directions) lies in a recent study demonstrating these cells alter their substrate 
utilisation depending upon time of day. This circadian microglial metabolism is disrupted 
under conditions of high-fat diet 116. These data raise the possibility of an indirect role for 
microglia in satiety; that disruptions to these cells may increase or decrease feeding at the 
wrong times of day with respect to their usual activity and metabolism. Another possibility 
that remains to be considered is that the role of microglia in satiety differs depending upon 
brain region or even upon as-yet-unidentified microglial subtypes. 
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Mechanisms for how microglia respond to and pass on feeding-related cues are yet untested 
but microglia do retain the capacity to respond directly to free fatty acids via their TLRs 117, 
and to phagocytose neuronal elements depending upon neuronal signals 11, 38-40, potentially 
including those derived from feeding-related circuits such as NPY/AgRP and POMC 
neurons. With respect to circadian rhythm variation, microglia also express a suite of clock 
genes that are highly responsive to dietary factors 116.  
 
5. Conclusion 
Research to date is scratching the surface of what microglia may do in the brain. As our tools 
improve, so will our understanding of the contribution of these cells to healthy brain function, 
including day-to-day functions such as feeding, cognition, and others. The data discussed in 
this review amply demonstrate that the contribution of these immune cells to higher order 
functions is far from simply explained. We anticipate future research will prove a bi-
directional relationship between microglia and both cognition and satiety. In doing this, it 
will be important to remember that the current knowledge on the diverse roles of microglia is 
based primarily on our discoveries in the rodent brain, more specifically the mouse brain. 
Although the transcriptomes of mouse and human microglia are largely conserved, there may 
also be distinct differences in a number of transcription factors and the expression of genes 
regulated by these factors 118, but also see 119. It is therefore essential to continue to expand 
our understanding of the translational relevance of our mechanistic insights. The field awaits 
a true integration of neuronal function with microglia and, indeed, other brain cell types to 
allow a full understanding of how we sense and interact with our environment.  
 
Figures 
Figure 1.  
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Microglial regulation of cognition in the adult brain. Changes in microglial activity alter 
cognitive function: microglial priming in response to aging or high-fat diet impairs cognition, 
while microglial activation, as occurs in response to a learning stimulus, leads to optimal 
cognition; suppression of microglial activity is unlikely to affect it. Microglial regulation of 
cognitive function may be achieved by their influences on neuronal turnover and synaptic 
remodelling: in response to a learning stimulus, microglial activity is likely to affect the 
survival of new neurons in the subgranular zone of the dentate gyrus leading to preferential 
survival of the more mature new neurons. Learning-induced microglial activation may also 
orchestrate strategic remodelling of dendritic spines, essential for successful cognition. 
Figure illustration assistance by Alison Schroeer. 
 
Figure 2.  
Microglial regulation of satiety. Evidence suggests changes in microglia can either 
encourage or discourage feeding and weight gain. Colony stimulating factor 1 receptor: CSF-
R1; High-fat diet: HDF; intracerebroventricular: icv; lipopolysaccharide: LPS; toll-like 
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